top of page
NIH Director Francis Collins Resigns
Sunday
FDA Approves Mirdametinib for NF1
Friday
NIH Cuts 'Indirect Costs' Funding - 15% Cap
Sunday
Itovebi Approved for Metastatic Breast Cancer
Monday
FDA Approves Novartis' Kisqali for Breast Cancer
Tuesday
NIH Director Francis Collins Resigns
Sunday
bottom of page